arrow
A

Alejandra Espinosa

universidad de valparaiso
H指数:34
被引数:3,696

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High-Fat Diet in Perinatal Period Promotes Liver Steatosis and Low Desaturation Capacity of Polyunsaturated Fatty Acids in Dams: A Link with Anxiety-Like Behavior in Rats

围产期高脂饮食促进母体肝脏脂肪变性及多不饱和脂肪酸去饱和能力低下:与大鼠焦虑样行为的关联

2025-03-280
OA
Characterizing Immune Infiltration in Metastatic Hormone Receptor-Positive/HER2Negative Breast Cancer: A Comprehensive Translational Analysis from four SOLTI Clinical Trials
2024-05-020
PRE
SOLTI-1718 NEREA Trial: Neratinib in hormone receptor (HR)-positive/HER2-negative HER2-enriched (HER2-E) advanced breast cancer (BC)
2024-05-020
PRE
A phase 2 randomized pre-operative,window of opportunity trial investigating the effect of elacestrant with/without triptorelin in premenopausal patients with HR+/HER2-breast cancer-SOLTI2104-PremiERe trial
2024-05-020
PRE
Targeting PAM50 HER2-Enriched intrinsic subtype with enzalutamide in hormone receptor- positive/HER2-negative (HR+/HER2-) advanced breast cancer: results of the SOLTI-1502 ARIANNA trial
2024-05-020
PRE
Mitofusin-2 induced by exercise modifies lipid droplet-mitochondria communication, promoting fatty acid oxidation in male mice with NAFLD
2024-03-017
PRE
SOLTI-1910: Predicting olaparib sensitivity in patients with unresectable locally advanced/metastatic HER2-negative breast cancer with BRCA1/2, PALB2, RAD51C/D mutations or HRD by the RAD51 test: RADIOLA TRIAL
2023-03-010
PRE
Elacestrant in postmenopausal women with estrogen receptor positive and HER2-negative early breast cancer: primary efficacy and safety analysis of the preoperative, window of opportunity SOLTI-1905-ELIPSE trial
2023-03-016
PRE